
Herquelen-TZ 281.25mg Injection
Marketer
Metamorf Lifesciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Herquelen-TZ 281.25mg Injection
Combiflox-TZ 281.25mg Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be solely under a healthcare provider's guidance. Complete the prescribed treatment regimen; premature cessation may compromise its effectiveness. Regularly scheduled doses are crucial. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, dyspnea) require prompt emergency care. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, drowsiness or dizziness warrants driving cessation. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Your physician may order lab tests to monitor the medication's efficacy.
Primary Ingredients of Herquelen-TZ 281.25mg Injection
No text provided to rephrase.
Uses of Herquelen-TZ 281.25mg Injection
Infections caused by bacteria
Major Benefits of Herquelen-TZ 281.25mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Herquelen-TZ 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Herquelen-TZ 281.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Herquelen-TZ 281.25mg Injection works:
Ceftriaxone/Tazobactum injection (Herquelen-TZ 281.25mg) unites two distinct drugs. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Herquelen-TZ 281.25mg Injection is not associated with adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Herquelen-TZ, 281.25mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Herquelen-TZ 281.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Herquelen-TZ 281.25mg Injection may induce drowsiness, blurred vision, or dizziness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Herquelen-TZ 281.25mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Herquelen-TZ 281.25mg Injection to individuals with severe hepatic impairment requires careful monitoring. Dosage modification of Herquelen-TZ 281.25mg Injection might be necessary; physician consultation is advised. Altering the Herquelen-TZ 281.25mg Injection dose is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Herquelen-TZ 281.25mg Injection :
Should you forget a dose of Herquelen-TZ 281.25mg Injection, seek your physician's advice.
Facts to Know About Herquelen-TZ 281.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
